All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


ProCE at AACN NTI - ExpoED Presentations

Planning to attend NTI 2019? Be sure to attend these ExpoED Presentations at ProCE Booth 2361

Register for NTI!

To attend these sessions, you must be registered for NTI

Nursing Considerations in the Management of Acute Major Bleeding

Pulmonary Arterial Hypertension: Meeting Critical Care Needs 


  • Tuesday, May 21 11:30 – 12:00 PM
  • Tuesday, May 21 1:45 – 2:15 PM
  • Tuesday, May 21 3:15 – 3:45PM
  • Wednesday, May 22 10:45 - 11:15 AM
  • Wednesday, May 22 12:15 – 12:45 PM
  • Wednesday, May 22 2:30 – 3:00 PM


  • Tuesday, May 21 10:45 – 11:15 AM
  • Tuesday, May 21 12:15 – 12:45 PM
  • Tuesday, May 22 2:30 – 3:00 PM
  • Wednesday, May 22 11:30 – 12:00 PM
  • Wednesday, May 22 1:45 – 2:15 PM
  • Wednesday, May 22 3:15 – 3:45 PM

This activity focuses on identified gaps in critical care and emergency nursing for acute major bleeding reversal, including risk factors, clinical impact, bleed stratification, and reversal agents that are available. A focus on dosing strategies, monitoring parameters, and safety data will conclude the session.

Learning Objectives:

  • Describe the pathophysiology, risk factors, and types of acute major bleeding
  • Discuss reversal agent selection, dosing strategies, and important monitoring parameters

Keri S. Kim, PharmD, MS-CTS, BCPS
Neurocritical Care Clinical Pharmacist
Clinical Assistant Professor
University of Illinois Health
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois

This session is provided by ProCE, Inc. and supported by an educational grant from Portola Pharmaceuticals, Inc.

This activity explores the role of critical care nurses in PAH patient care, including opportunities to assess adherence, potential missed diagnoses by increasing awareness of the disease, and valuable treatment considerations – especially during transitions of care.

Learning Objectives:

  • Distinguish PAH from other types of illnesses with similar signs and symptoms in the critically ill patient
  • Outline the latest clinical practice guidelines and discuss strategies to advocate for and assist with transitions of care for the PAH patient

Amy Kimber, RN, APNP
Nurse Practitioner for the Pulmonary Hypertension Program
Froedtert & the Medical College of Wisconsin
Milwaukee, Wisconsin

This session is provided by ProCE, Inc. and supported by an educational grant from Actelion Pharmaceuticals US, Inc.

CE Accreditation


Each educational offering is for 0.5 Synergy CERP, Category A continuing education for nurses.


It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Faculty disclosures will be announced at the beginning of the CE activity.

Please note: The opinions expressed in this activity should not be construed as those of the CE provider. The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.